Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extranodal T- and NK-cell lymphomas. | Virchows Arch | 2023 | 36336765 | PubTator, text mining | PubMed |
| Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. | Leukemia | 2023 | 36333583 | PubTator, text mining | PubMed |
| C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse. | Blood | 2023 | 36322939 | PubTator, text mining | PubMed |
| Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker. | Cancer Res | 2023 | 36318117 | PubTator, text mining | PubMed |
| Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. | Mol Diagn Ther | 2023 | 36287372 | PubTator, text mining | PubMed |
| Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia. | Int J Hematol | 2023 | 36279042 | PubTator, text mining | PubMed |
| Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations. | Cancer Commun (Lond) | 2023 | 36250318 | PubTator, text mining | PubMed |
| DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: Implications for clonal evolution and disease progression. | Hematol Oncol | 2023 | 36131612 | PubTator, text mining | PubMed |
| First Case of ETV6-RUNX1 Fusion in Adult De Novo Acute Myeloid Leukemia Detected Using Targeted RNA Sequencing. | Ann Lab Med | 2023 | 36045062 | PubTator, text mining | PubMed |
| Clinical and Cytogenetic Characteristics of Children With Leukemia 20-Year Retrospective Study. | J Pediatr Hematol Oncol | 2023 | 36044298 | PubTator, text mining | PubMed |
| Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia. | Haematologica | 2023 | 36005562 | PubTator, text mining | PubMed |
| Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives. | Blood Rev | 2023 | 35989139 | PubTator, text mining | PubMed |
| Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia. | Blood Adv | 2023 | 35984639 | PubTator, text mining | PubMed |
| Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern. | Drug Deliv Transl Res | 2023 | 35930221 | PubTator, text mining | PubMed |
| Analysis of rare driving events in pediatric acute myeloid leukemia. | Haematologica | 2023 | 35899387 | PubTator, text mining | PubMed |
| Exploration of the breast ductal carcinoma in situ signature and its prognostic implications. | Cancer Med | 2023 | 35880695 | PubTator, text mining | PubMed |
| Epidural Spinal Cord Compression as the Presenting Manifestation of Acute Myeloid Leukemia: A Case Report and Literature Review. | Intern Med | 2023 | 35793962 | PubTator, text mining | PubMed |
| Crosstalk between β-catenin and WT1 signaling activity in acute myeloid leukemia. | Haematologica | 2023 | 35443562 | PubTator, text mining | PubMed |
| Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile. | Hematol Transfus Cell Ther | 2023 | 34690101 | PubTator, text mining | PubMed |
| Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors. | BMJ Support Palliat Care | 2023 | 33941573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=25